BSE - Delayed Quote INR
Amrutanjan Health Care Limited (AMRUTANJAN.BO)
692.80
+13.70
+(2.02%)
At close: April 30 at 3:29:15 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
4,423,550
4,201,206
3,782,252
4,045,460
3,325,334
Cost of Revenue
2,179,441
2,118,268
1,819,786
1,804,625
1,401,852
Gross Profit
2,244,109
2,082,938
1,962,466
2,240,835
1,923,482
Operating Expense
1,718,498
1,602,759
1,541,827
1,421,103
1,128,455
Operating Income
525,611
480,179
420,639
819,732
795,027
Net Non Operating Interest Income Expense
144,859
145,540
115,604
105,880
87,964
Pretax Income
678,828
619,460
536,454
905,766
819,045
Tax Provision
185,669
169,734
138,105
233,877
207,141
Net Income Common Stockholders
493,159
449,726
398,349
671,889
611,904
Diluted NI Available to Com Stockholders
493,159
449,726
398,349
671,889
611,904
Basic EPS
17.04
15.50
13.65
23.00
20.94
Diluted EPS
17.04
15.50
13.63
22.98
20.93
Basic Average Shares
28,943.32
29,019.92
29,178.40
29,207.61
29,221.92
Diluted Average Shares
28,943.32
29,019.92
29,226.62
29,236.80
29,236.56
Rent Expense Supplemental
--
7,083
4,100
2,545
3,496
Total Expenses
3,897,939
3,721,027
3,361,613
3,225,728
2,530,307
Net Income from Continuing & Discontinued Operation
493,159
449,726
398,349
671,889
611,904
Normalized Income
498,660.68
455,223.24
400,141.40
688,029.88
670,886.80
Interest Income
--
148,049
117,830
111,699
93,884
Interest Expense
2,248
1,567
771
4,845
5,000
Net Interest Income
144,859
145,540
115,604
105,880
87,964
EBIT
681,076
621,027
537,225
910,611
824,045
EBITDA
745,455
681,596
589,340
948,563
860,742
Reconciled Cost of Revenue
2,179,441
2,118,268
1,819,786
1,804,625
1,401,852
Reconciled Depreciation
64,379
60,569
52,115
37,952
36,697
Net Income from Continuing Operation Net Minority Interest
493,159
449,726
398,349
671,889
611,904
Total Unusual Items Excluding Goodwill
-7,573
-7,573
-2,414
-21,762
-78,949
Total Unusual Items
-7,573
-7,573
-2,414
-21,762
-78,949
Normalized EBITDA
753,028
689,169
591,754
970,325
939,691
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,071.32
-2,075.76
-621.61
-5,621.12
-19,966.20
3/31/2021 - 5/18/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade